Journal of Neurology

, Volume 262, Issue 9, pp 2083–2091 | Cite as

Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study

  • Mark Obermann
  • Eva Bock
  • Nikolay Sabev
  • Nils Lehmann
  • Ralph Weber
  • Marcus Gerwig
  • Markus Frings
  • Diana Arweiler-Harbeck
  • Stephan Lang
  • Hans-Christoph Diener
Original Communication


To investigate the long-term outcome of interdisciplinary treatment in a tertiary care neuro-otology institution after 2 years as part of the Dizziness and Vertigo Registry study. Risk factors associated with unfavourable outcome were assessed. 3113 consecutive patients with disorders of vertigo and dizziness were recruited prospectively between March 2010 and February 2012. Patients were clinically assessed and treated according to their diagnosis. Standardized instruments were used at baseline and at 2-year follow-up [Dizziness Handicap Inventory (DHI), Quality of Life Questionnaire, General Depression Scale, Stait-Trait Anxiety Index], as well as a custom health-related questionnaire. The primary outcome variable of this observational study was the change in DHI after 2 years. Patients suffered from phobic postural vertigo (23 %), benign peripheral paroxysmal vertigo (14.4 %), unilateral vestibulopathy (10.5 %), central vestibular disorders (8 %), Menière’s disease (9.8 %), vestibular migraine (6.9 %), bilateral vestibulopathy (5.5 %), and vestibular paroxysmia (3.1 %). Mean disease duration was 4.6 ± 6.3 years. 1272 patients were available for follow-up, 1159 completed the DHI score. 72.1 % of patients improved in DHI score from baseline to 2 years follow-up. Mean reduction in DHI score was 14 points (p = 0.02). Long-term outcome following diagnosis and treatment in a specialized tertiary care centre is good and persistent after 2 years. Risk factors for an unfavourable outcome were advanced age, severe disability, constant vertigo or dizziness, and concomitant back pain, while depression and anxiety did not contribute to this risk considerably.


Tertiary care Dizziness Vertigo Treatment centre Long-term follow-up 



We would like to thank Prof. Thomas Brandt for his valuable input, revision, and constructive criticism of this manuscript.

Conflicts of interest

Mark Obermann has received scientific support and/or honoraria from Biogen Idec, Novartis, Sanofi-Aventis, Genzyme, Pfizer, Teva and Heel. He received research grants from Allergan, Electrocore, Heel, and the German Ministry for Education and Research (BMBF). Eva Bock has nothing to disclose. Nikolay Sabev has nothing to disclose. Nils Lehmann has nothing to disclose. Ralph Weber received honoria for oral presentations from Boehringer Ingelheim. Bristol-Myers Squibb and Covidien. Marcus Gerwig has nothing to disclose. Markus Frings has nothing to disclose. Diana Arweiler-Harbeck has nothing to disclose. Stephan Lang has nothing to disclose. Hans-Christoph Diener has received honoraria for participation in clinical trials, contribution to advisory boards or lectures from Addex Pharma, Allergan, Almirall, AstraZeneca, Bayer Vital, Berlin Chemie, Coherex Medical, CoLucid, Böhringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Grünenthal, Janssen-Cilag, Lilly, La Roche, 3 M Medica, Minster, MSD, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper and Brümmer, SanofiAventis, and Weber & Weber; received research support from Allergan, Almirall, AstraZeneca, Bayer, Galaxo-Smith-Kline, Janssen-Cilag, and Pfizer. Research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF), and the European Union.

Supplementary material

415_2015_7803_MOESM1_ESM.docx (160 kb)
Supplementary material 1 (DOCX 160 kb)


  1. 1.
    Hannaford PC, Simpson JA, Bisset AF, Davis A, McKerrow W, Mills R (2005) The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Fam Pract 22(3):227–233CrossRefPubMedGoogle Scholar
  2. 2.
    Yardley L, Owen N, Nazareth I, Luxon L (1998) Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract J R Coll Gen Pract 48(429):1131–1135Google Scholar
  3. 3.
    Kroenke K, Price RK (1993) Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 153(21):2474–2480CrossRefPubMedGoogle Scholar
  4. 4.
    Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T et al (2005) Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 65(6):898–904CrossRefPubMedGoogle Scholar
  5. 5.
    Sloane PD (1989) Dizziness in primary care. Results from the national ambulatory medical care survey. J Fam Pract 29(1):33–38PubMedGoogle Scholar
  6. 6.
    Best C, Eckhardt-Henn A, Diener G, Bense S, Breuer P, Dieterich M (2006) Interaction of somatoform and vestibular disorders. J Neurol Neurosurg Psychiatry 77(5):658–664PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Jacobson GP, Newman CW (1990) The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 116(4):424–427CrossRefPubMedGoogle Scholar
  8. 8.
    Equilibrium CoHa (1995) Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease. Am Acad Otolaryngol Head Neck Found Inc Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 113(3):181–185CrossRefGoogle Scholar
  9. 9.
    Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J et al (2012) Vestibular migraine: diagnostic criteria. J Vestib Res Equilib Orientat 22(4):167–172Google Scholar
  10. 10.
    Brandt T, Huppert D, Dieterich M (1994) Phobic postural vertigo: a first follow-up. J Neurol 241(4):191–195CrossRefPubMedGoogle Scholar
  11. 11.
    Prokopakis E, Vlastos IM, Tsagournisakis M, Christodoulou P, Kawauchi H, Velegrakis G (2013) Canalith repositioning procedures among 965 patients with benign paroxysmal positional vertigo. Audiol Neurootol 18(2):83–88CrossRefPubMedGoogle Scholar
  12. 12.
    Prokopakis EP, Chimona T, Tsagournisakis M, Christodoulou P, Hirsch BE, Lachanas VA et al (2005) Benign paroxysmal positional vertigo: 10-year experience in treating 592 patients with canalith repositioning procedure. Laryngoscope 115(9):1667–1671CrossRefPubMedGoogle Scholar
  13. 13.
    Sekine K, Imai T, Sato G, Ito M, Takeda N (2006) Natural history of benign paroxysmal positional vertigo and efficacy of Epley and Lempert maneuvers. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 135(4):529–533CrossRefGoogle Scholar
  14. 14.
    von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T et al (2007) Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 78(7):710–715CrossRefGoogle Scholar
  15. 15.
    Sato G, Sekine K, Matsuda K, Takeda N (2013) Risk factors for poor outcome of a single Epley maneuver and residual positional vertigo in patients with benign paroxysmal positional vertigo. Acta Otolaryngol 133(11):1124–1127CrossRefPubMedGoogle Scholar
  16. 16.
    Tschan R, Best C, Wiltink J, Beutel ME, Dieterich M, Eckhardt-Henn A (2013) Persistence of symptoms in primary somatoform vertigo and dizziness: a disorder “lost” in health care? J Nerv Ment Dis 201(4):328–333CrossRefPubMedGoogle Scholar
  17. 17.
    Holmberg J, Karlberg M, Harlacher U, Magnusson M (2007) One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol 254(9):1189–1192CrossRefPubMedGoogle Scholar
  18. 18.
    Ruckenstein MJ, Staab JP (2009) Chronic subjective dizziness. Otolaryngol Clin N Am 42(1):71–77 (ix) CrossRefGoogle Scholar
  19. 19.
    Kaderli R, Seelandt J, Umer M, Tschan F, Businger A (2013) Reasons for the persistence of adverse events in the era of safer surgery—a qualitative approach. Swiss Med Wkly 143:w13882PubMedGoogle Scholar
  20. 20.
    Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K et al (2008) Long-term prophylactic treatment of attacks of vertigo in Menière’s disease—comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 128(5):520–524CrossRefPubMedGoogle Scholar
  21. 21.
    Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA (2014) Treatment adherence in patients with headache: a systematic review. Headache 54(5):795–816CrossRefPubMedGoogle Scholar
  22. 22.
    Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular migraine. J Neurol 256(3):333–338CrossRefPubMedGoogle Scholar
  23. 23.
    Best C, Eckhardt-Henn A, Tschan R, Dieterich M (2009) Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol 256(1):58–65CrossRefPubMedGoogle Scholar
  24. 24.
    Yoon MS, Manack A, Schramm S, Fritsche G, Obermann M, Diener HC et al (2013) Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German Headache Consortium study. Pain 154(3):484–492CrossRefPubMedGoogle Scholar
  25. 25.
    Karatas M (2008) Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes. Neurol 14(6):355–364CrossRefGoogle Scholar
  26. 26.
    Brown KE, Whitney SL, Marchetti GF, Wrisley DM, Furman JM (2006) Physical therapy for central vestibular dysfunction. Arch Phys Med Rehabil 87(1):76–81CrossRefPubMedGoogle Scholar
  27. 27.
    Hillier SL, McDonnell M (2011) Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev (2):CD005397Google Scholar
  28. 28.
    Zingler VC, Weintz E, Jahn K, Mike A, Huppert D, Rettinger N et al (2008) Follow-up of vestibular function in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry 79(3):284–288CrossRefPubMedGoogle Scholar
  29. 29.
    Gillespie MB, Minor LB (1999) Prognosis in bilateral vestibular hypofunction. Laryngoscope 109(1):35–41CrossRefPubMedGoogle Scholar
  30. 30.
    Krebs DE, Gill-Body KM, Parker SW, Ramirez JV, Wernick-Robinson M (2003) Vestibular rehabilitation: useful but not universally so. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 128(2):240–250CrossRefGoogle Scholar
  31. 31.
    Eleftheriadou A, Skalidi N, Velegrakis GA (2012) Vestibular rehabilitation strategies and factors that affect the outcome. Eur Arch Oto Rhino Laryngol Off J Eur Fed Oto Rhino Laryngol Soc 269(11):2309–2316CrossRefGoogle Scholar
  32. 32.
    Geser R, Straumann D (2012) Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol 3:169PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Mark Obermann
    • 1
    • 5
  • Eva Bock
    • 2
  • Nikolay Sabev
    • 1
  • Nils Lehmann
    • 2
  • Ralph Weber
    • 4
  • Marcus Gerwig
    • 1
  • Markus Frings
    • 1
  • Diana Arweiler-Harbeck
    • 3
  • Stephan Lang
    • 3
  • Hans-Christoph Diener
    • 1
  1. 1.Department of NeurologyUniversity of Duisburg-EssenEssenGermany
  2. 2.Institute for Medical Informatics Biometry and EpidemiologyUniversity of Duisburg-EssenEssenGermany
  3. 3.Department of OtorhinolaryngologyUniversity of Duisburg-EssenEssenGermany
  4. 4.Department of NeurologyAlfried-Krupp-Hospital EssenEssenGermany
  5. 5.Center for NeurologyAsklepios Hospitals SchildautalSeesenGermany

Personalised recommendations